Literature DB >> 22511737

On the edge: targeting Toll-like receptor 2 in ischemia/reperfusion injury.

Philipp M Lepper, Robert Bals.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22511737     DOI： 10.1161/CIRCINTERVENTIONS.112.968495

Source DB:  PubMed          Journal:  Circ Cardiovasc Interv        ISSN： 1941-7640            Impact factor:   6.546


× No keyword cloud information.
  4 in total

Review 1.  Update on ischemia-reperfusion injury in kidney transplantation: Pathogenesis and treatment.

Authors:  Maurizio Salvadori; Giuseppina Rosso; Elisabetta Bertoni
Journal:  World J Transplant       Date:  2015-06-24

2.  Atorvastatin Improves Ventricular Remodeling after Myocardial Infarction by Interfering with Collagen Metabolism.

Authors:  Karla Reichert; Helison Rafael Pereira do Carmo; Anali Galluce Torina; Daniela Diógenes de Carvalho; Andrei Carvalho Sposito; Karlos Alexandre de Souza Vilarinho; Lindemberg da Mota Silveira-Filho; Pedro Paulo Martins de Oliveira; Orlando Petrucci
Journal:  PLoS One       Date:  2016-11-23       Impact factor: 3.240

3.  RP105 plays a cardioprotective role in myocardial ischemia reperfusion injury by regulating the Toll‑like receptor 2/4 signaling pathways.

Authors:  Weiling Huang; Jian Yang; Chao He; Jun Yang
Journal:  Mol Med Rep       Date:  2020-06-16       Impact factor: 2.952

Review 4.  Minimizing Ischemia Reperfusion Injury in Xenotransplantation.

Authors:  Parth M Patel; Margaret R Connolly; Taylor M Coe; Anthony Calhoun; Franziska Pollok; James F Markmann; Lars Burdorf; Agnes Azimzadeh; Joren C Madsen; Richard N Pierson
Journal:  Front Immunol       Date:  2021-09-09       Impact factor: 7.561
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.